USCIS has issued a rare second Notice of Intent to Deny (NOID) for an EB-1A petition, raising concerns about the agency’s adjudication process. Helen Partlow, Managing Attorney at Waypoint Immigration USA, reported this unusual case, where the applicant specializes in pharmaceutical drug development. The second NOID cites perceived inconsistencies in the applicant’s field description, which is typically not a common reason for denial.

Key Details:

This case exemplifies the increasing scrutiny faced by EB-1A applicants, potentially impacting their immigration outcomes. Need help with your immigration case? Visit QuickFiling.us for professional immigration services.


Source: Helen Partlow (Managing Attorney, Waypoint Immigration USA)

Start searching

Enter keywords to search articles

↑↓
ESC
⌘K Shortcut